Acute promyelocytic leukemia (APL) is a rare, highly treatable form of acute myeloid leukemia (1). The paucity of studies conducted in Central and South America hint towards a higher prevalence of APL among descendants of Spaniards, as compared to other ethnic groups (2) (3) (4) . At present, a comprehensive study that delineates potential disparities in APL incidence across Europe has yet been reported.
CIs were calculated per 100,000 person-years for the overall cohort and four age groups, and by country.
Our analytic cohort included 1,876 patients with APL, of whom 48% were male and 24% aged ≥65 years. The overall ASR of APL was 0.112 (95% CI, 0.107-0.117) in Europe, with similar ASRs between males (0.111; 95% CI, 0.103-0.118) and females (0.114; 95% CI, 0.107-0.122). The age-specific incidence rates of APL were 0.034 (95% CI, 0.028-0.042), 0.077 (95% CI, 0.066-0.090), 0.138 (95% CI, 0.130-0.146), and 0.181 (95% CI, 0.165-0.198) in the age groups 0-14, 15-24, 25-64, and ≥65 years, respectively. The incidence of APL varied markedly across Europe, with the highest incidence in Spain (0.257; 95% CI, 0.205-0.317; Figure 1 ). Of note, particular country-specific estimates should be interpreted with caution, as small sample sizes increase the wideness of 95% CIs and made it expedient to compute rates without age standardization. Furthermore, aspects related to underregistration and/or under-diagnosis of cases might plague particular registries and/or countries, particularly in Austria, Bulgaria, Poland, Finland, Latvia, and Croatia.
Collectively, the incidence of APL was the highest in Spain, as compared to the European average. This finding adds further support to the hypothesis that APL might be more prevalent among individuals with Spanish ancestry. Notwithstanding this finding, environmental factors might also influence susceptibility to APL. Therefore, forthcoming studies are warranted to specifically investigate etiologic factors of APL across different genetic and environmental backgrounds.
of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The current study was performed with publicly available data from the RARECAREnet database (http://www.rarecarenet.eu/).
